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Background: The purpose of this report is to describe the association of severe anterior uveitis with type II
essential cryoglobulinemia.
Findings: A 40-year-old male with a history of psoriatic arthritis presented with severe anterior uveitis associated
with type II essential cryoglobulinemia. His uveitis, refractory to steroid treatments, was well controlled following
treatments for cryoglobulinemia. The temporal association between his cryoglobulinemia and uveitis, combined
with his improved visual acuity and inflammation after plasmapheresis and rituximab infusions, suggests
cryoglobulinemia to be the underlying condition of his uveitis.
Conclusions: To our best knowledge, this is the first reported case of anterior uveitis secondary to type II essential
cryoglobulinemia.
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Introduction
Cryoglobulinemia is a rare condition characterized by the
presence of immunoglobulins that precipitate in the blood
at low temperatures [1]. Type I (simple) cryoglobulinemia
results from monoclonal immunoglobulins, usually IgM
and IgG, and is associated with lymphoproliferative disor-
ders. Types II and III (mixed) cryoglobulinemias involve
rheumatoid factors that form complexes with the Fc
portion of IgG and can be associated with chronic infec-
tious diseases as well as autoimmune and neoplastic condi-
tions [1]. When no underlying condition is identified,
the cryoglobulinemia is termed ‘essential’. Although
cryoglobulinemia is primarily known to involve the joints,
kidneys, and skin, a few cases of eye manifestations have
been reported [2-4]. Type I cryoglobulinemia has been as-
sociated with moderate anterior uveitis and anterior seg-
ment ischemia [2]. Isolated anterior segment ischemia
without inflammation has also been demonstrated in type
II cryoglobulinemia [2]. Scleritis and peripheral ulcerative
keratitis have been reported with hepatitis C-related type
III cryoglobulinemia [3]. One case of anterior uveitis has* Correspondence: Lucia_Sobrin@meei.harvard.edu
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reproduction in any medium, provided the origalso been reported in a patient with cutaneous vasculitis
and an unspecified type of cryoglobulinemia [4]. We de-
scribe a patient with severe anterior uveitis secondary to
type II essential cryoglobulinemia. To our best knowledge,
this is the first reported case of this association.
Case report
A 40-year-old male with a history of psoriatic arthritis
presented with blurred vision in both eyes. His visual
acuities were 20/80 in the right eye and 20/70 in the left
eye. Intraocular pressures were 20 and 18, respectively.
He had 4+ anterior chamber cell according to SUN cri-
teria [5], fine keratic precipitates, bilateral posterior
synechiae, no hypopyon, and normal fundus examina-
tions in both eyes. Fluorescein angiography demon-
strated bilateral disc leakage. Concomitantly, the patient
was admitted for dyspnea, leg swelling, and fever and
was found to have crescentic cryoglobulinemic glomer-
ulonephritis and pulmonary capillaritis on kidney and
lung biopsies, respectively. Cryoprotein was also identi-
fied in the serum consisting of two components, an IgG
kappa and an IgM kappa, consistent with type II
cryoglobulinemia. The patient had negative hepatitis C
serologies, was negative for syphilis and HLA-B27, and
showed no evidence of tuberculosis on a chest CT scan.
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had not been treated with any immunosuppressive ther-
apies for his psoriatic arthritis in the past. He received
hourly difluprednate drops for 3 weeks for his uveitis as
well as concomitant intravenous pulse dose methylpred-
nisolone followed by prednisone (60 mg daily) and oral
cyclophosphamide (150 mg daily) for his glomerulo-
nephritis. Despite receiving all of the above therapies for
at least 2 weeks, he continued to have 4+ anterior cham-
ber cells in both eyes. He underwent six sessions of
plasmapheresis along with four intravenous rituximab
infusions of 795 mg each over a 1-month period. Pulse
methylprednisolone was given with the initial rituximab
infusions. Over the course of these treatments, the pa-
tient’s plasma creatinine returned to normal levels, there
were no plasma cryoglobulins present, and the inflam-
mation in both eyes was resolved. His visual acuity im-
proved to 20/20 in both eyes. At a 1-month follow-up,
the patient had no anterior chamber cells, and at a 6-
month follow-up, he remained taking 5 mg of prednis-
one with no evidence of cryoglobulinemia.
Discussion
Although the association between psoriasis and anterior
uveitis is well established [6], several aspects of this pa-
tient’s case indicate that his anterior uveitis was second-
ary to type II essential cryoglobulinemia rather than his
psoriatic arthritis. First, there is a temporal relationship
between the development of anterior uveitis and
cryoglobulinemia. The patient presented with uveitis and
was discovered to have type II essential cryoglobulinemia
within a 2-week period. It remains possible that the
cryoglobulinemia was incidental and that the timing of
these conditions were unrelated. However, the patient
had psoriatic arthritis for many years without developing
uveitis, and his psoriatic arthritis was well controlled at
the time he presented with intraocular inflammation.
Second, the patient’s uveitis was refractory to a 2-week
regimen of traditional treatments (topical and systemic
steroids) for anterior uveitis secondary to psoriasis. In
contrast, his visual acuity improved immediately follow-
ing the initiation of the rituximab and plasmapheresis he
received for his type II essential cryoglobulinemia. This
is consistent with reports of uveitis secondary to other
types of cryoglobulinemia where ocular inflammation
was unresponsive to topical steroids [2,4] and oral pred-
nisone [2], with the case of type I cryoglobulinemia-
associated uveitis also being subsequently responsive to
rituximab and plasmapheresis therapy [2].
There is evidence that circulating immune complexes
are implicated in the pathogenesis of some uveitis cases.
Animal models of serum sickness, a circulating immune
complex disease, have been shown to develop cellular in-
filtrates in the uvea [7]. We hypothesize that thecirculating immune complexes in our patient with type
II essential cryoglobulinemia led to cellular infiltration in
the anterior chamber in an analogous fashion to that
seen in the serum sickness animal model. Thus, type II
essential cryoglobulinemia should be considered in the
differential diagnosis of anterior uveitis, especially in the
setting of systemic manifestations of vasculitis. This is
particularly important because, at least based on the few
cases reported in the literature thus far, uveitis secondary
to cryoglobulinemia may be refractory to traditional
therapy with corticosteroids and may require more ag-
gressive treatments like plasmapheresis and rituximab to
clear the body of the culprit antibodies and restore
vision.
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